Dapar, Baby Boy .
HRN: 21-32-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/13/2022
05/19/2022
IV
14.5mg
OD
Non Institutional Delivery
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes